FIELD: medicine.
SUBSTANCE: invention represents a method for assessing the quality of blood plasma D-dimer detection in the clinical diagnostic laboratory environment, involving analysing reference materials and comparing the analysis results to target values; the method is characterised by choosing a reference procedure most exactly matching with the target values; the D-dimer concentration in two levels of certified reference materials is measured at least twice with the use of the assessed and chosen reference procedures; a match coefficient of the assessed and chosen reference procedures is determined by the following formula: CC = (Yav high-Yav low)/(Xav high-Xav low); the analysis results produced by the assessed procedure are multiplied by the match coefficient, compared to the results produced by the chosen reference procedure, and the quality of blood plasma D-dimer detection is assessed.
EFFECT: invention enables providing more accurate assessment of the quality of D-dimer detection and improving D-dimer detection standardisation.
2 ex, 1 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR LETHAL OUTCOME PREDICTION FOR INTENSIVE CARE PATIENTS OF CARDIOSURGICAL PROFILE | 2016 |
|
RU2626674C1 |
METHOD OF DIAGNOSTICS OF INFLAMMATORY LESIONS OF UPPER GIT | 2018 |
|
RU2672600C1 |
METHOD FOR EVALUATING QUALITY OF CLINICAL LABORATORY RESEARCH | 2006 |
|
RU2304282C1 |
METHOD OF DETECTING THROMBINEMIA IN LARGE JOINT REPLACEMENT | 2009 |
|
RU2423697C2 |
METHOD FOR THROMBOEMBOLIC COMPLICATIONS PREDICTION | 2016 |
|
RU2621298C1 |
DIAGNOSTICS OF THROMBOEMBOLIC VEIN DISEASES BY DETERMINATION OF CONTENT OF D-DIMERS AND SOLUBLE FIBRIN | 2007 |
|
RU2475760C2 |
DIAGNOSTIC TECHNIQUE FOR COAGULATION FAILURES IN PREGNANT WOMEN IN TRIMESTER 2-3 | 2014 |
|
RU2543653C1 |
METHOD FOR DETECTING HYPERCOAGULATION AND INTRAVASCULAR COAGULATION ACTIVATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA IN MANIFESTATION | 2012 |
|
RU2497127C1 |
METHOD FOR EVALUATING PLASMA HAEMOSTASIS | 2023 |
|
RU2816538C1 |
METHOD FOR PREDICTING PULMONARY ARTERIAL EMBOLIZATION IN ONCOLOGY PATIENTS WITH LOWER EXTREMITY PHLEBOTHROMBOSIS | 2016 |
|
RU2664448C2 |
Authors
Dates
2015-12-27—Published
2014-09-15—Filed